MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisDamiano Rondelli, Robert S. Hoffman, Marco Scarano et al.|Blood|2014Cited by 153
Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with MyelofibrosisDamiano Rondelli, Robert S. Hoffman, Judith D. Goldberg et al.|Transplantation and Cellular Therapy|2012Cited by 10
Towards a Better Understanding of Epidemiology, Survival and Treatment in Myeloproliferative Neoplasms: Results of the European Leukemianet Registry (ERNEST study)Tiziano Barbui, Claire Harrison, Arianna Masciulli et al.|Blood|2014Cited by 6
Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with MyelofibrosisDamiano Rondelli, Robert S. Hoffman, Judith D. Goldberg et al.|Blood|2011Cited by 3